The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
Open accessAbstract
Phase II metabolic enzymes are a battery of critical proteins that detoxify xenobiotics by increasing their hydrophilicity and enhancing their disposal. These enzymes have long been studied for their preventative and protective effects against mutagens and carcinogens and for their regulation via the Keap1 (Kelch-like ECH associated protein 1) / Nrf2 (Nuclear factor erythroid 2 related factor 2) / ARE (antioxidant response elements) pathway. Recently, a series of studies have reported the altered expression of phase II genes in postmortem tissue of patients with various neurological diseases. These observations hint at a role for phase II enzymes in the evolution of such conditions. Furthermore, promising findings reveal that overexpression of phase II genes, either by genetic or chemical approaches, confers neuroprotection in vitro and in vivo. Therefore, there is a need to summarize the current literature on phase II genes in the central nervous system (CNS). This should help guide future studies on phase II genes as therapeutic targets in neurological diseases. In this review, we first briefly introduce the concept of phase I, II and III enzymes, with a special focus on phase II enzymes. We then discuss their expression regulation, their inducers and executors. Following this background, we expand our discussion to the neuroprotective effects of phase II enzymes and the potential application of Nrf2 inducers to the treatment of neurological diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Nuclear Import and Export Signals in Control of Nrf2
Jain, A. K., Bloom, D. A., & Jaiswal, A. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502083200 · Cited by 195
RetractedWang, X., Wang, Y., Kim, H. P., Nakahira, K., Ryter, S. W., & Choi, A. M. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607610200 · Cited by 192
RetractedPhosphorylation of Tyrosine 568 Controls Nuclear Export of Nrf2
Jain, A. K., & Jaiswal, A. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511198200 · Cited by 172
RetractedProthymosin-α Mediates Nuclear Import of the INrf2/Cul3·Rbx1 Complex to Degrade Nuclear Nrf2
Niture, S. K., & Jaiswal, A. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808084200 · Cited by 69
RetractedExploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“Epidemiological studies show that ALS is sporadic in 90–95% of cases and familial in 5–10% of cases, and that approximately 10%–20% of familial ALS cases are caused by the mutations in the ubiquitously expressed Cu/Zn SOD antioxidant protein (Rosen, 1993).”
BackgroundMotor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Bilirubin Is an Antioxidant of Possible Physiological Importance
Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., & Ames, B. N. (1987) · Science · doi:10.1126/science.3029864 · Cited by 2,948
Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Huntington's disease: from molecular pathogenesis to clinical treatment
Ross, C. A., & Tabrizi, S. J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,743
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740
Zhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Carbon Monoxide: a Putative Neural Messenger
Verma, A., Hirsch, D. J., Glatt, C. E., Ronnett, G. V., & Snyder, S. H. (1993) · Science · doi:10.1126/science.7678352 · Cited by 1,563
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · cited 2×
“As a nucleophile, Cys151 is sensitive to many inducers and is therefore considered to be a stress sensor (McMahon et al., 2010; Zhang and Hannink, 2003).”
BackgroundMolecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., & Yamamoto, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16023 · Cited by 1,460
Intracerebral haemorrhage: mechanisms of injury and therapeutic targets
Keep, R. F., Hua, Y., & Xi, G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70104-7 · Cited by 1,308
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279
Regulatory Mechanisms Controlling Gene Expression Mediated by the Antioxidant Response Element
Nguyen, T., Sherratt, P. J., & Pickett, C. B. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140229 · Cited by 1,236
Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival
Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J., & Diehl, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7198-7209.2003 · Cited by 1,234
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155 · cited 3×
“However, it is generally accepted that the proliferation of CNS-infiltrated immune cells, such as T cells, damage oligodendrocytes and axons via neuroinflammation and oxidative stress (Frohman et al., 2006; Linker et al., 2011).”
BackgroundRamos-Gomez, M., Kwak, M.-K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., & Kensler, T. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051618798 · Cited by 1,102
Huang, H.-C., Nguyen, T., & Pickett, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206911200 · Cited by 1,034
The cytoprotective role of the Keap1–Nrf2 pathway
Baird, L., & Dinkova-Kostova, A. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0674-5 · Cited by 1,027
Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M.-I., Kobayashi, A., Yamamoto, M., Kensler, T. W., & Talalay, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307301101 · Cited by 986 · cited 1×
“Oxidation of these cysteines changes the structure of Keap1 and reduces its affinity for Nrf2 (Wakabayashi et al., 2004) (Figure 3C).”
BackgroundKobayashi, A., Kang, M.-I., Watai, Y., Tong, K. I., Shibata, T., Uchida, K., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.221-229.2006 · Cited by 933
Enzymatic Synthesis of Deoxyribonucleotides
Laurent, T. C., Moore, E. C., & Reichard, P. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)97742-2 · Cited by 931
Rosen, D. (1993) · Nature · doi:10.1038/364362c0 · Cited by 922
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
Hayes, J. D., & McMahon, M. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.12.008 · Cited by 869
Clements, C. M., McNally, R. S., Conti, B. J., Mak, T. W., & Ting, J. P.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607260103 · Cited by 818 · cited 1×
“Furthermore, tBHQ can no longer induce the nuclear translocation of Nrf2 in DJ-1 knockout mice (Clements et al., 2006; Gan et al., 2010).”
BackgroundItoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., O'Connor, T., & Yamamoto, M. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00640.x · Cited by 816
Shih, A. Y., Johnson, D. A., Wong, G., Kraft, A. D., Jiang, L., Erb, H., Johnson, J. A., & Murphy, T. H. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03394.2003 · Cited by 785
Molecular mechanisms of Nrf2‐mediated antioxidant response
Li, W., & Kong, A. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20465 · Cited by 785
Dringen, R., Gutterer, J. M., & Hirrlinger, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01597.x · Cited by 760
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
Tong, K. I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2887-2900.2006 · Cited by 759 · cited 1×
“The ETGF motif (KD ≈ 1000 nmol/L) has a higher affinity for Keap1 than the DLG motif (KD ≈ 5.3 nmol/L) (Tong et al., 2006).”
BackgroundInfluentialRada, P., Rojo, A. I., Chowdhry, S., McMahon, M., Hayes, J. D., & Cuadrado, A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01204-10 · Cited by 759 · cited 3×
“This model is supported by the stabilization of Nrf2 by GSK-3β inhibitors in Keap1 -/- mouse embryo fibroblasts (MEFs) (Rada et al., 2011).”
BackgroundInfluentialShibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728
Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D., & Zhang, D. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.029 · Cited by 638 · cited 17×
“Using transgenic mice with Nrf2 under control of an astrocyte-specific promoter on both Nrf2+/+ and Nrf2-/- backgrounds, Peichun and colleagues showed that only astrocytes with Nrf2 expression can abolish the neurotoxicity of MPTP (Chen et al., 2009a).”
BackgroundInfluentialKobayashi, M., Li, L., Iwamoto, N., Nakajima-Takagi, Y., Kaneko, H., Nakayama, Y., Eguchi, M., Wada, Y., Kumagai, Y., & Yamamoto, M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01080-08 · Cited by 638
PHASE II DRUG METABOLIZING ENZYMES
Jancova, P., Anzenbacher, P., & Anzenbacherova, E. (2010) · Biomedical Papers · doi:10.5507/bp.2010.017 · Cited by 603
Dringen, R., Pfeiffer, B., & Hamprecht, B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00562.1999 · Cited by 589 · cited 1×
“Specifically, astrocytes provide neurons directly with glutathione (Anderson et al., 2003; Dringen et al., 2000), or provide the precursors for GSH synthesis, such as Cys-Gly and γGlu-Cys from the hydrolysis of GSH (Dringen et al. , 1999; Qin et al., 2006).”
BackgroundChen, P.-C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813361106 · Cited by 579
Kraft, A. D., Johnson, D. A., & Johnson, J. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3817-03.2004 · Cited by 541
Huang, H.-C., Nguyen, T., & Pickett, C. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220418997 · Cited by 539
Kang, M.-I., Kobayashi, A., Wakabayashi, N., Kim, S.-G., & Yamamoto, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308347100 · Cited by 534
Bloom, D. A., & Jaiswal, A. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307633200 · Cited by 525
Mustacich, D. J., & Powis, G. (2000) · PubMed · Cited by 517
Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity
Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J., Motohashi, H., & Yamamoto, M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01704-07 · Cited by 513
McMahon, M., Thomas, N., Itoh, K., Yamamoto, M., & Hayes, J. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601119200 · Cited by 485
Jain, A. K., & Jaiswal, A. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611336200 · Cited by 483
Kappos, L., Gold, R., Miller, D. H., MacManus, D. G., Havrdova, E., Limmroth, V., Polman, C. H., Schmierer, K., Yousry, T. A., Yang, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61619-0 · Cited by 482
The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
Innamorato, N. G., Rojo, A. I., García-Yagüe, À. J., Yamamoto, M., de Ceballos, M. L., & Cuadrado, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.680 · Cited by 480
Vargas, M. R., Johnson, D. A., Sirkis, D. W., Messing, A., & Johnson, J. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4099-08.2008 · Cited by 479
Rada, P., Rojo, A. I., Evrard-Todeschi, N., Innamorato, N. G., Cotte, A., Jaworski, T., Tobón-Velasco, J. C., Devijver, H., García-Mayoral, M. F., Van Leuven, F., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00180-12 · Cited by 474
Rhee, S. G., & Woo, H. A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3393 · Cited by 463
Scannevin, R. H., Chollate, S., Jung, M.-Y., Shackett, M., Patel, H., Bista, P., Zeng, W., Ryan, S., Yamamoto, M., Lukashev, M., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190132 · Cited by 461
Motohashi, H., O'Connor, T., Katsuoka, F., Engel, J. D., & Yamamoto, M. (2002) · Gene · doi:10.1016/s0378-1119(02)00788-6 · Cited by 459
Properties and Biological Activities of Thioredoxins
Powis, G., & Montfort, W. R. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.261 · Cited by 451
Chemoprotection against cancer by Phase 2 enzyme induction
Talalay, P., Fahey, J. W., Holtzclaw, W. D., Prestera, T., & Zhang, Y. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03553-2 · Cited by 444
McMahon, M., Lamont, D. J., Beattie, K. A., & Hayes, J. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007387107 · Cited by 443
Tong, K. I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S., & Yamamoto, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00753-07 · Cited by 442
Pharmacogenomics, Regulation and Signaling Pathways of Phase I and II Drug Metabolizing Enzymes
Rushmore, T. H., & Kong, A.-N. T. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337171 · Cited by 424
Dhakshinamoorthy, S., Jain, A. K., Bloom, D. A., & Jaiswal, A. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500166200 · Cited by 414 · cited 1×
“Free Maf protein then forms a heterodimer with Nrf2 and triggers the expression of downstream genes (Dhakshinamoorthy et al., 2005; Sun et al., 2004).”
BackgroundShih, A. Y., Li, P., & Murphy, T. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4014-05.2005 · Cited by 413
Atomic structure and chemistry of human serum albumin
He, X. M., & Carter, D. C. (1993) · Nature · doi:10.1038/364362b0 · Cited by 413
Mechanism of Heme Oxygenase-1 Gene Activation by Cadmium in MCF-7 Mammary Epithelial Cells
Alam, J., Wicks, C., Stewart, D., Gong, P., Touchard, C., Otterbein, S., Choi, A. M. K., Burow, M. E., & Tou, J.-S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004729200 · Cited by 407
Activation of NRF2 by Nitrosative Agents and H2O2 Involves KEAP1 Disulfide Formation
Fourquet, S., Guerois, R., Biard, D., & Toledano, M. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051714 · Cited by 379
Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease
Rojo, A. I., Innamorato, N. G., Martín‐Moreno, A. M., De Ceballos, M. L., Yamamoto, M., & Cuadrado, A. (2010) · Glia · doi:10.1002/glia.20947 · Cited by 375
Risk factors for and management of cognitive dysfunction in multiple sclerosis
Benedict, R. H. B., & Zivadinov, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.61 · Cited by 370
The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm
Zipper, L. M., & Mulcahy, R. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206530200 · Cited by 366 · cited 1×
“It is thought to serve as a dimerization domain, maintaining the dimer structure of Keap1 because mutation of Ser140 in BTB leads to the dedimerization of Keap1 and subsequent release of Nrf2 (Zipper and Mulcahy, 2002).”
BackgroundSun, J., Brand, M., Zenke, Y., Tashiro, S., Groudine, M., & Igarashi, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308083100 · Cited by 364 · cited 1×
“Free Maf protein then forms a heterodimer with Nrf2 and triggers the expression of downstream genes (Dhakshinamoorthy et al., 2005; Sun et al., 2004).”
BackgroundRegulation of Neuronal Glutathione Synthesis
Aoyama, K., Watabe, M., & Nakaki, T. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r01cr · Cited by 360
Zhou, W., & Freed, C. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507124200 · Cited by 346
Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage
Takagi, Y., Mitsui, A., Nishiyama, A., Nozaki, K., Sono, H., Gon, Y., Hashimoto, N., & Yodoi, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.4131 · Cited by 336
Properties and Biological Activities of Thioredoxins
Powis, G., & Montfort, W. R. (2001) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.30.1.421 · Cited by 336
Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage
Wang, J., & Dore, S. (2007) · Brain · doi:10.1093/brain/awm095 · Cited by 333
Reduction of Cysteine Sulfinic Acid by Sulfiredoxin Is Specific to 2-Cys Peroxiredoxins
Woo, H. A., Jeong, W., Chang, T.-S., Park, K. J., Park, S. J., Yang, J. S., & Rhee, S. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c400496200 · Cited by 331
Nakaso, K., Yano, H., Fukuhara, Y., Takeshima, T., Wada-Isoe, K., & Nakashima, K. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00517-9 · Cited by 326
Numazawa, S., Ishikawa, M., Yoshida, A., Tanaka, S., & Yoshida, T. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00043.2003 · Cited by 317
Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement
Schipper, H. M., Song, W., Zukor, H., Hascalovici, J. R., & Zeligman, D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06160.x · Cited by 298 · cited 1×
“HO-1 has a short half-life, about 3 hr for messenger RNA and 15-21 hr for protein (Dwyer et al., 1992; Leautaud and Demple, 2007; Schipper et al., 2009).”
BackgroundMechanisms of L-Cysteine Neurotoxicity
Janáky, R., Varga, V., Hermann, A., Saransaari, P., & Oja, S. S. (2000) · Neurochemical Research · doi:10.1023/a:1007616817499 · Cited by 291
Yu, R., Lei, W., Mandlekar, S., Weber, M. J., Der, C. J., Wu, J., & Kong, A.-N. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27545 · Cited by 281
Enhancing Expression of Nrf2-Driven Genes Protects the Blood–Brain Barrier after Brain Injury
Zhao, J., Moore, A. N., Redell, J. B., & Dash, P. K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1683-07.2007 · Cited by 274
The electrophile counterattack response: Protection against neoplasia and toxicity
Prestera, T., Zhang, Y., Spencer, S. R., Wilczak, C. A., & Talalay, P. (1993) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(93)90024-8 · Cited by 256
Nuclear factor erythroid 2-related factor 2 protects against beta amyloid
Kanninen, K., Malm, T. M., Jyrkkänen, H.-K., Goldsteins, G., Keksa-Goldsteine, V., Tanila, H., Yamamoto, M., Ylä-Herttuala, S., Levonen, A.-L., & Koistinaho, J. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.07.010 · Cited by 255
Raza, H. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08358.x · Cited by 251
Nrf2-mediated protection against 6-hydroxydopamine
Jakel, R. J., Townsend, J. A., Kraft, A. D., & Johnson, J. A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.131 · Cited by 250
Singh, A., Rangasamy, T., Thimmulappa, R. K., Lee, H., Osburn, W. O., Brigelius-Flohé, R., Kensler, T. W., Yamamoto, M., & Biswal, S. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0325oc · Cited by 248
Calkins, M. J., Jakel, R. J., Johnson, D. A., Chan, K., Kan, Y. W., & Johnson, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408487101 · Cited by 247
Gene expression profiling of NRF2-mediated protection against oxidative injury
Cho, H.-Y., Reddy, S. P., DeBiase, A., Yamamoto, M., & Kleeberger, S. R. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.013 · Cited by 246
Biomolecules under mechanical force
Kumar, S., & Li, M. S. (2010) · Physics Reports · doi:10.1016/j.physrep.2009.11.001 · Cited by 244
Mustacich, D. J., & Powis, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460001 · Cited by 231
Apopa, P. L., He, X., & Ma, Q. (2008) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20212 · Cited by 230
Lee, J.-M., Hanson, J. M., Chu, W. A., & Johnson, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100734200 · Cited by 228
Transcription Factor Nrf2 Protects the Brain From Damage Produced by Intracerebral Hemorrhage
Zhao, X., Sun, G., Zhang, J., Strong, R., Dash, P. K., Kan, Y. W., Grotta, J. C., & Aronowski, J. (2007) · Stroke · doi:10.1161/strokeaha.107.486506 · Cited by 227
Wang, B., Zhu, X., Kim, Y., Li, J., Huang, S., Saleem, S., Li, R.-C., Xu, Y., Dore, S., & Cao, W. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.12.006 · Cited by 224
Role of Nrf2 in protection against intracerebral hemorrhage injury in mice
Wang, J., Fields, J., Zhao, C., Langer, J., Thimmulappa, R. K., Kensler, T. W., Yamamoto, M., Biswal, S., & Doré, S. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.04.020 · Cited by 224
Dinkova-Kostova, A. T., Holtzclaw, W. D., & Wakabayashi, N. (2005) · Biochemistry · doi:10.1021/bi047434h · Cited by 219
Nakata, K., Tanaka, Y., Nakano, T., Adachi, T., Tanaka, H., Kaminuma, T., & Ishikawa, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.437 · Cited by 215
Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury
Shah, Z. A., Li, R.-C., Thimmulappa, R. K., Kensler, T. W., Yamamoto, M., Biswal, S., & Doré, S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.066 · Cited by 213
The role of oxidative stress and NADPH oxidase in cerebrovascular disease
Chrissobolis, S., & Faraci, F. M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.09.003 · Cited by 211
Neymotin, A., Calingasan, N. Y., Wille, E., Naseri, N., Petri, S., Damiano, M., Liby, K. T., Risingsong, R., Sporn, M., Beal, M. F., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.027 · Cited by 210
An Auto-regulatory Loop between Stress Sensors INrf2 and Nrf2 Controls Their Cellular Abundance
Lee, O.-H., Jain, A. K., Papusha, V., & Jaiswal, A. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706517200 · Cited by 204
Johnson, D. A., Amirahmadi, S., Ward, C., Fabry, Z., & Johnson, J. A. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfp274 · Cited by 203
Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS
Kirby, J., Halligan, E., Baptista, M. J., Allen, S., Heath, P. R., Holden, H., Barber, S. C., Loynes, C. A., Wood-Allum, C. A., Lunec, J., et al. (2005) · Brain · doi:10.1093/brain/awh503 · Cited by 200
Theodore, M., Kawai, Y., Yang, J., Kleshchenko, Y., Reddy, S. P., Villalta, F., & Arinze, I. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709040200 · Cited by 198
Yu, R., Mandlekar, S., Lei, W., Fahl, W. E., Tan, T.-H., & Kong, A.-N. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2322 · Cited by 196
Rojo, A. I., Medina-Campos, O. N., Rada, P., Zúñiga-Toalá, A., López-Gazcón, A., Espada, S., Pedraza-Chaverri, J., & Cuadrado, A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.003 · Cited by 194
Regulation of Nrf2 Transactivation Domain Activity
Shen, G., Hebbar, V., Nair, S., Xu, C., Li, W., Lin, W., Keum, Y.-S., Han, J., Gallo, M. A., & Kong, A.-N. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401368200 · Cited by 194
In vivo modulation of the Parkinsonian phenotype by Nrf2
Burton, N. C., Kensler, T. W., & Guilarte, T. R. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.07.019 · Cited by 187
Tufekci, K. U., Civi Bayin, E., Genc, S., & Genc, K. (2011) · Parkinson's Disease · doi:10.4061/2011/314082 · Cited by 182
Sarlette, A., Krampfl, K., Grothe, C., Neuhoff, N. V., Dengler, R., & Petri, S. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818b4906 · Cited by 178
Kim, K. M., Pae, H.-O., Zheng, M., Park, R., Kim, Y.-M., & Chung, H.-T. (2007) · Circulation Research · doi:10.1161/circresaha.107.154781 · Cited by 177
Wruck, C. J., Claussen, M., Fuhrmann, G., Römer, L., Schulz, A., Pufe, T., Waetzig, V., Peipp, M., Herdegen, T., & Götz, M. E. (2007) · Neuropsychiatric Disorders An Integrative Approach · doi:10.1007/978-3-211-73574-9_9 · Cited by 176
Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease
Ellrichmann, G., Petrasch‐Parwez, E., Lee, D.-H., Reick, C., Arning, L., Saft, C., Gold, R., & Linker, R. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016172 · Cited by 176
Eggler, A. L., Small, E., Hannink, M., & Mesecar, A. D. (2009) · Biochemical Journal · doi:10.1042/bj20090471 · Cited by 176
Nrf2 Possesses a Redox-sensitive Nuclear Exporting Signal in the Neh5 Transactivation Domain
Li, W., Yu, S., & Kong, A.-N. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602746200 · Cited by 175
Ferrandiz, M., & Devesa, I. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783597399 · Cited by 174
Astrocytes and Stroke: Networking for Survival?
Anderson, M. F., Blomstrand, F., Blomstrand, C., Eriksson, P. S., & Nilsson, M. (2003) · Neurochemical Research · doi:10.1023/a:1022385402197 · Cited by 173
Tanito, M., Agbaga, M.-P., & Anderson, R. E. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.018 · Cited by 173
Jin, W., Wang, H., Yan, W., Xu, L., Wang, X., Zhao, X., Yang, X., Chen, G., & Ji, Y. (2008) · Mediators of Inflammation · doi:10.1155/2008/725174 · Cited by 172
Stack, C., Ho, D., Wille, E., Calingasan, N. Y., Williams, C., Liby, K., Sporn, M., Dumont, M., & Beal, M. F. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.017 · Cited by 169
Matz, P., Turner, C., Weinstein, P. R., Massa, S. M., Panter, S. S., & Sharp, F. R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01511-6 · Cited by 163
The Roles of Thioredoxin in Protection against Oxidative Stress-induced Apoptosis in SH-SY5Y Cells
Andoh, T., Chock, P. B., & Chiueh, C. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110701200 · Cited by 162
Chowdhury, I., Mo, Y., Gao, L., Kazi, A., Fisher, A. B., & Feinstein, S. I. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.027 · Cited by 159
Elsby, R., Kitteringham, N. R., Goldring, C. E., Lovatt, C. A., Chamberlain, M., Henderson, C. J., Wolf, C. R., & Park, B. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301211200 · Cited by 159
Köhle, C., & Bock, K. W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.020 · Cited by 157
Lin, S. X., Lisi, L., Russo, C. D., Polak, P. E., Sharp, A. J., Weinberg, G. L., Kalinin, S., & Feinstein, D. L. (2011) · ASN NEURO · doi:10.1042/an20100033 · Cited by 156
Hu, X., Weng, Z., Chu, C. T., Zhang, L., Cao, G., Gao, Y., Signore, A. P., Zhu, J., Hastings, T. G., Greenamyre, J. T., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4589-10.2011 · Cited by 156
Self-citationWang, Z., Ma, C., Meng, C., Zhu, G., Sun, X., Huo, L., Zhang, J., Liu, H., He, W., Shen, X., et al. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.00978.x · Cited by 156
Holtzclaw, W. D., Dinkova‐Kostova, A. T., & Talalay, P. (2004) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2003.11.013 · Cited by 154
Structure of the sulphiredoxin–peroxiredoxin complex reveals an essential repair embrace
Jönsson, T. J., Johnson, L. C., & Lowther, W. T. (2008) · Nature · doi:10.1038/nature06415 · Cited by 153
Chaturvedi, R. K., Calingasan, N. Y., Yang, L., Hennessey, T., Johri, A., & Beal, M. F. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq229 · Cited by 152
Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction
Hancock, R., Bertrand, H. C., Tsujita, T., Naz, S., El-Bakry, A., Laoruchupong, J., Hayes, J. D., & Wells, G. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.486 · Cited by 151
Innamorato, N. G., Jaźwa, A., Rojo, A. I., García, C., Fernández‐Ruíz, J., Grochot‐Przeczek, A., Stachurska, A., Józkowicz, A., Dulak, J., & Cuadrado, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011838 · Cited by 150
Anti-apoptotic Effect of cGMP in Cultured Astrocytes
Takuma, K., Phuagphong, P., Lee, E., Mori, K., Baba, A., & Matsuda, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108622200 · Cited by 149
Hong, Y., Yan, W. X., Chen, S., Sun, C., & Zhang, J. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.101 · Cited by 146
Soriano, F. X., Léveillé, F., Papadia, S., Higgins, L. G., Varley, J. A., Baxter, P. S., Hayes, J. D., & Hardingham, G. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05648.x · Cited by 146
Pehar, M., Vargas, M. R., Robinson, K. M., Cassina, P., Díaz‐Amarilla, P., Hagen, T. M., Radí, R., Barbeito, L., & Beckman, J. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0823-07.2007 · Cited by 145
Lim, J. H., Kim, K., Kim, S. W., Hwang, O., & Choi, H. J. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.03.004 · Cited by 145
Effects of Deferoxamine on Intracerebral Hemorrhage-Induced Brain Injury in Aged Rats
Okauchi, M., Hua, Y., Keep, R. F., Morgenstern, L. B., & Xi, G. (2009) · Stroke · doi:10.1161/strokeaha.108.535765 · Cited by 143
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions
van Horssen, J., Drexhage, J., Flor, T., Gerritsen, W. H., van der Valk, P., & de Vries, H. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.07.013 · Cited by 143
Barone, M. C., Sykiotis, G. P., & Bohmann, D. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007575 · Cited by 139
Chen, G., Fang, Q., Zhang, J., Zhou, D., & Wang, Z. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22577 · Cited by 138
Qin, S., Colin, C., Hinners, I., Gervais, A., Cheret, C., & Mallat, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5186-05.2006 · Cited by 135 · cited 1×
“Specifically, astrocytes provide neurons directly with glutathione (Anderson et al., 2003; Dringen et al., 2000), or provide the precursors for GSH synthesis, such as Cys-Gly and γGlu-Cys from the hydrolysis of GSH (Dringen et al. , 1999; Qin et al., 2006).”
BackgroundThe Emerging Role of the Thioredoxin System in Angiogenesis
Dunn, L., Buckle, A., Cooke, J. P., & Ng, M. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.209643 · Cited by 134
Bell, K. F., Al-Mubarak, B., Fowler, J. H., Baxter, P. S., Gupta, K., Tsujita, T., Chowdhry, S., Patani, R., Chandran, S., Horsburgh, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015229108 · Cited by 133
Rojo, A. I., Rada, P., Egea, J., Rosa, A. O., López, M. G., & Cuadrado, A. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.06.007 · Cited by 133
Kim, Y., Yamaguchi, Y., Kondo, N., Masutani, H., & Yodoi, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206369 · Cited by 131
Huntington’s disease: pathogenesis to animal models
Kumar, P., Kalonia, H., & Kumar, A. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70238-3 · Cited by 129
Hattori, I., Takagi, Y., Nakamura, H., Nozaki, K., Bai, J., Kondo, N., Sugino, T., Nishimura, M., Hashimoto, N., & Yodoi, J. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604771978372 · Cited by 127
Tanaka, N., Ikeda, Y., Ohta, Y., Deguchi, K., Tian, F., Shang, J., Matsuura, T., & Abe, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.010 · Cited by 124
Keap1‐Nrf2 activation in the presence and absence of DJ‐1
Gan, L., Johnson, D. A., & Johnson, J. A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07138.x · Cited by 119
Vacuolar Leukoencephalopathy with Widespread Astrogliosis in Mice Lacking Transcription Factor Nrf2
Hubbs, A. F., Benkovic, S. A., Miller, D. B., O'Callaghan, J. P., Battelli, L. A., Schwegler‐Berry, D., & Ma, Q. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060898 · Cited by 119
Jin, W., Wang, H., Ji, Y., Hu, Q., Yan, W. X., Chen, G., & Hongxia, Y. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.005 · Cited by 118
Cytoprotective Nrf2 Pathway Is Induced In Chronically Txnrd 1-Deficient Hepatocytes
Suvorova, E. S., Lucas, O., Weisend, C. M., Rollins, M. F., Merrill, G. F., Capecchi, M. R., & Schmidt, E. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006158 · Cited by 115
Kraft, A. D., Lee, J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04019.x · Cited by 113
Emerging roles of thioredoxin cycle enzymes in the central nervous system
Patenaude, A., Murthy, M. R. V., & Mirault, M.-É. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4541-5 · Cited by 112
Miyazaki, I., Asanuma, M., Diaz-Corrales, F. J. J., Fukuda, M., Kitaichi, K., Miyoshi, K., & Ogawa, N. (2006) · The FASEB Journal · doi:10.1096/fj.05-4996fje · Cited by 111
Role of Nrf2 in Protection against Traumatic Brain Injury in Mice
Jin, W., Wang, H., Yan, W. X., Zhu, L., Hu, Z., Ding, Y., & Tang, K. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0655 · Cited by 108
Pareek, T. K., Belkadi, A., Kesavapany, S., Zaremba, A., Loh, S. L., Bai, L., Cohen, M. L., Meyer, C. J., Liby, K. T., Miller, R. H., et al. (2011) · Scientific Reports · doi:10.1038/srep00201 · Cited by 108
Escartin, C., Won, S. J., Malgorn, C., Aurégan, G., Berman, A., Chen, P., Déglon, N., Johnson, J. A., Suh, S. W., & Swanson, R. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6577-10.2011 · Cited by 107
Activation of Nrf2–ARE pathway in brain after traumatic brain injury
Yan, W. X., Wang, H., Hu, Z.-G., Wang, Q.-F., & Yin, H.-X. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.060 · Cited by 100
Nrf2 Possesses a Redox-insensitive Nuclear Export Signal Overlapping with the Leucine Zipper Motif
Li, W., Jain, M. R., Chen, C., Yue, X., Hebbar, V., Zhou, R., & Kong, A.-N. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410601200 · Cited by 100
Ichikawa, T., Li, J., Meyer, C. J., Janicki, J. S., Hannink, M., & Cui, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008391 · Cited by 99 · cited 1×
“Dihydro-CDDO-trifluoroethyl amide (CDDO-TFEA), a newly identified potent inducer, also belongs to this group (Ichikawa et al., 2009).”
BackgroundBenzene, NQO1, and genetic susceptibility to cancer
Smith, M. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7624 · Cited by 98
Zhang, F., Wang, S., Zhang, M., Weng, Z., Li, P., Gan, Y., Zhang, L., Cao, G., Gao, Y., Leak, R. K., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.647420 · Cited by 96
Self-citationTransactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax
Masutani, H., Hirota, K., Sasada, T., Ueda-Taniguchi, Y., Taniguchi, Y., Sono, H., & Yodoi, J. (1996) · Immunology Letters · doi:10.1016/s0165-2478(96)02651-x · Cited by 84
Heme oxygenase is a heat shock protein and PEST protein in rat astroglial cells
Dwyer, B. E., Nishimura, R. N., de Vellis, J., & Yoshida, T. (1992) · Glia · doi:10.1002/glia.440050407 · Cited by 84
Eftekharpour, E., Holmgren, A., & Juurlink, B. H. J. (2000) · Glia · doi:10.1002/1098-1136(200009)31:3<241::aid-glia50>3.0.co;2-9 · Cited by 81
Gan, Y., Ji, X., Hu, X., Luo, Y., Zhang, L., Li, P., Liu, X., Yan, F., Vosler, P. S., Gao, Y., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4298 · Cited by 81
Self-citationExpression of novel antioxidant thioredoxin‐2 in the rat brain
Rybnikova, E. A., Damdimopoulos, A. E., Gustafsson, J.-Α., Spyrou, G., & Pelto‐Huikko, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00059.x · Cited by 80
Glutathione‐S‐transferase P1 is a critical regulator of Cdk5 kinase activity
Sun, K., Chang, K., Clawson, S., Ghosh, S., Mirzaei, H., Regnier, F. E., & Shah, K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07343.x · Cited by 79
Munemasa, Y., Ahn, J. H., Kwong, J. M. K., Caprioli, J., & Piri, N. (2008) · Gene Therapy · doi:10.1038/gt.2008.126 · Cited by 79
An Autoregulatory Loop between Nrf2 and Cul3-Rbx1 Controls Their Cellular Abundance
Kaspar, J. W., & Jaiswal, A. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121863 · Cited by 76
Localization of thioredoxin in the rat brain and functional implications
Lippoldt, A., Padilla, C. A., Gerst, H., Andbjer, B., Richter, E., Holmgren, A., & Fuxé, K. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06747.1995 · Cited by 75
Ahlgren-Beckendorf, J. A., Reising, A. M., Schander, M. A., Herdler, J. W., & Johnson, J. A. (1999) · Glia · doi:10.1002/(sici)1098-1136(19990115)25:2<131::aid-glia4>3.0.co;2-6 · Cited by 75
Barhwal, K. K., Hota, S. K., Jain, V., Prasad, D. N., Singh, S. B., & Ilavazhagan, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.086 · Cited by 74
Xiao, H., Lv, F., Xu, W., Zhang, L., Jing, P., & Cao, X. (2011) · Toxicology · doi:10.1016/j.tox.2011.10.007 · Cited by 70
van Roon‐Mom, W., Pepers, B. A., Hoen, P. A. C. ’., Verwijmeren, C., den Dunnen, J. T., Dorsman, J. C., & van Ommen, G. B. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-84 · Cited by 70
Deguchi, K., Hayashi, T., Nagotani, S., Sehara, Y., Zhang, H., Tsuchiya, A., Ohta, Y., Tomiyama, K., Morimoto, N., Miyazaki, M., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.07.104 · Cited by 69
Santamaría, A., Pérez‐Severiano, F., Rodríguez-Martínez, E., Maldonado, P. D., Pedraza‐Chaverrí, J., Ríos, C., & Segovia, J. (2001) · Neurochemical Research · doi:10.1023/a:1010911417383 · Cited by 69
Wakade, C. G., King, M. D., Laird, M. D., Alleyne, C. H., & Dhandapani, K. M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2056 · Cited by 67
Heme oxygenase-1 gene therapy for prevention of vasospasm in rats
Ono, S., Komuro, T., & Macdonald, R. L. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.96.6.1094 · Cited by 67
Dopamine activates Nrf2‐regulated neuroprotective pathways in astrocytes and meningeal cells
Shih, A. Y., Erb, H., & Murphy, T. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04345.x · Cited by 60
Bae, S. H., Woo, H. A., Sung, S. H., Lee, H. E., Lee, S. K., Kil, I. S., & Rhee, S. G. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2325 · Cited by 59
Jin, W., Zhu, L., Guan, Q., Chen, G., Wang, Q. F., Yin, H. X., Hang, C. H., Shi, J. X., & Wang, H. D. (2008) · PubMed · Cited by 56
Zhang, J., Zhu, Y., Zhou, D., Wang, Z., & Chen, G. (2010) · Cytokine · doi:10.1016/j.cyto.2010.08.011 · Cited by 53
Neuroprotective Effect of Curcumin in an Experimental Rat Model of Subarachnoid Hemorrhage
Kuo, C.-P., Lu, C., Wen, L., Cherng, C., Wong, C., Borel, C. O., Ju, D., Chen, C., & Wu, C. (2011) · Anesthesiology · doi:10.1097/aln.0b013e31823306f0 · Cited by 52
Ono, S., Zhang, Z., Marton, L. S., Yamini, B., Windmeyer, E., Johns, L., Kowalczuk, A., Lin, G., & Macdonald, R. L. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200007000-00006 · Cited by 50
Correa, F., Ljunggren, E., Mallard, C. E., Nilsson, M., Weber, S. G., & Sandberg, M. (2011) · Glia · doi:10.1002/glia.21151 · Cited by 49
D’Ascenzo, M., Martinotti, G., Azzena, G. B., & Grassi, C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07485.2002 · Cited by 48
Du, Y., Zhang, X., Ji, H., Liu, H., Li, S., & Li, L. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2011.12.054 · Cited by 46
Feeser, V. R., & Loria, R. M. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.06.007 · Cited by 46
Neurodegeneration and peroxidases
Everse, J., & Coates, P. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.007 · Cited by 45
Chen, M., & Regan, R. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04885.x · Cited by 44
Cited by
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Melatonin: an ancient molecule that makes oxygen metabolically tolerable
Manchester, L. C., Coto‐Montes, A., Boga, J. A., Andersen, L. P. H., Zhou, Z., Galano, A., Vriend, J., Tan, D., & Reiter, R. J. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12267 · Cited by 945
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837
“Nrf2 status has been linked to many kinds of neurodegenerative disorders, such as Parkinson disease, multiple sclerosis, Huntington disease, Alzheimer disease, and amyotrophic lateral sclerosis (reviewed in [461, 462]).”
The Roles of NRF2 in Modulating Cellular Iron Homeostasis
Kerins, M. J., & Ooi, A. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7176 · Cited by 738
Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 678
Metadata
- Authors
- Zhang, M., An, C., Gao, Y., Leak, R. K., Chen, J., & Zhang, F.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 100
- Pages
- 30-47
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W1977334935
- Cited by
- 617
- References
- 215
- FWCI
- 12.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.